Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
ReplyLetter

Dr. Rossides, et al reply

MARIOS ROSSIDES, JULIA F. SIMARD, ELISABET SVENUNGSSON, MIA VON EULER and ELIZABETH V. ARKEMA
The Journal of Rheumatology July 2018, 45 (7) 1070; DOI: https://doi.org/10.3899/jrheum.180122
MARIOS ROSSIDES
Karolinska Institutet, Clinical Epidemiology Division, Department of Medicine Solna, Stockholm, Sweden;
MD, MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: marios.rossides{at}ki.se
JULIA F. SIMARD
Stanford School of Medicine, Health Research and Policy, Division of Epidemiology, Stanford, California, USA, and Karolinska Institutet, Clinical Epidemiology Division, Department of Medicine Solna;
ScD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ELISABET SVENUNGSSON
Karolinska Institutet, Rheumatology Unit, Department of Medicine Solna and Karolinska University Hospital;
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MIA VON EULER
Karolinska Institutet, Stroke Research Network, Södersjukhuset, and Karolinska Institutet, Department of Clinical Science and Education;
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ELIZABETH V. ARKEMA
Karolinska Institutet, Clinical Epidemiology Division, Department of Medicine Solna, Stockholm, Sweden.
ScD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

To the Editor:

We thank Dr. Băicuş for his interest1 in our investigation of the mortality and functionality after stroke in individuals with systemic lupus erythematosus (SLE)2. In our article, we reported that the median age at stroke onset in individuals with SLE was 68 years for ischemic stroke and 65 for hemorrhagic stroke2. The mean time from SLE diagnosis to stroke onset was about 3 years for both stroke types, with great variability around the mean2. We stress that reporting the mean and SD might be useful for data description even in cases in which a variable is not normally distributed3.

Nonetheless, and given the opportunity of Dr. Băicuş’s commentary, we have estimated the median age at SLE diagnosis; it was 59 years for ischemic stroke [interquartile range (IQR) 46–69 yrs] and 51 years for hemorrhagic stroke (IQR 40–63 yrs). It is important to distinguish between the age at SLE onset and the age at SLE diagnosis. The first we cannot readily identify with our data. The latter we can only approximate for some because the outpatient component of the National Patient Register became available in 2001, 3 years after study start. This means that for some of the patients included, their first diagnosis in our data was identified from the inpatient component only. Moreover, we should note that a higher age at SLE diagnosis is anticipated because our study population was restricted to individuals with SLE and stroke, and as we have shown in an earlier publication, stroke is rarer in individuals with SLE who are younger than 60 years4.

REFERENCES

  1. 1.↵
    1. Băicuş C
    . At what age was SLE diagnosed in this cohort? J Rheumatol 2018;45:1070.
    OpenUrlFREE Full Text
  2. 2.↵
    1. Rossides M,
    2. Simard JF,
    3. Svenungsson E,
    4. von Euler M,
    5. Arkema EV
    . Mortality and functionality after stroke in patients with systemic lupus erythematosus. J Rheumatol 2017;44:1590–6.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Lydersen S
    . Statistical review: frequently given comments. Ann Rheum Dis 2015;74:323–5.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Arkema EV,
    2. Svenungsson E,
    3. von Euler M,
    4. Sjowall C,
    5. Simard JF
    . Stroke in systemic lupus erythematosus: a Swedish population-based cohort study. Ann Rheum Dis 2017;76:1544–9.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 45, Issue 7
1 Jul 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Dr. Rossides, et al reply
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Dr. Rossides, et al reply
MARIOS ROSSIDES, JULIA F. SIMARD, ELISABET SVENUNGSSON, MIA VON EULER, ELIZABETH V. ARKEMA
The Journal of Rheumatology Jul 2018, 45 (7) 1070; DOI: 10.3899/jrheum.180122

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Dr. Rossides, et al reply
MARIOS ROSSIDES, JULIA F. SIMARD, ELISABET SVENUNGSSON, MIA VON EULER, ELIZABETH V. ARKEMA
The Journal of Rheumatology Jul 2018, 45 (7) 1070; DOI: 10.3899/jrheum.180122
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • To the Editor:
    • REFERENCES
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Early-Onset Calcium Pyrophosphate Disease Associated With Genetic Hypomagnesemia: Beyond Gitelman Syndrome
  • Juvenile Arthritis Quality of Life Questionnaire Responder Metrics in Juvenile Idiopathic Arthritis: Clarifying Health-Related Quality of Life Changes Across Treatment Eras
  • Dr. Tsai et al reply
Show more Letter

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire